- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
St. John's,NL
2013 FACE meeting
Orlando, Florida
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting
.
-
Jul192012
-
Mar292012
-
Jul282011
-
Jan272011
- Read more in our News Archive
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
The Cancer in Pregnancy Forum
Archived Questions and AnswersThis Forum has been the centre of an exceptional exchange of knowledge diagnosis, treatment, symptoms and other effects of cancer during pregnancy and lactation. All are welcome to review the Questions and Answers posted here, provided that they acknowledge and accept the important proviso and disclaimer below.
CCoPE
Date: 2007-10-30
Question:
I have a 16 yr Old friend that is 22 weeks pregnant and has aml. They have told her to terminate the pregnancy , deliver at 24 weeks or go to full term and not have the treatment until baby is born. Can anyone give me some info, support etc for her
Many thanks
Kat
Answer:
The following information should not replace the assessment and advice you have been receiving from your physician (cancer specialist, obstetrician, or any other healthcare provider). It is offered for your information only. Consult your physician.
There is very little data regarding AML during pregnancy, most information is regarding ALL. However, in a large series from Japan, the authors could not find any adverse effects of ALL on pregnancy during late pregnancy (Int J Hematol 1998;67:37-43).
A case report of a 23 year old female diagnosed with AML at 23 weeks who received combined chemotherapy for treatment of the cancer, her child was delivered with no congenital abnormalities and follow-up at 5 years showed no neurologic or hematologic abnormalities (Int J Gynecol Obstet 1994;44:273-277).
In general, chemoptherapuetic agents cannot cause malformations beyond the first trimester and fetal toxicity has rarely been described.
There are numerous treatment options available, and it is important to discuss the safety of administering them during pregnancy with the physician or oncologist. It is important that the patient be closely followed by her physician throughout the pregnancy.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)